Quick Summary
Encicarb 1K Injection
Last updated on 28 Oct 2026 | 12:42 PM (IST)
₹3688
MRP: ₹6085.31
(You Save ₹2397.31)
1 VIAL(s) OF 20ML
Encicarb 1K Injection
Salt Composition
FERRIC CARBOXYMALTOSEMarketer
EMCURE PHARMACEUTICALS LTD
39% OFF
₹3688
MRP: ₹6,085.31
Inclusive of all taxes
39% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Nefcm 1000mg Injection
ERIS LIFESCIENC...
₹ 1264.00/injection
65% cheaper
Fanemia 1000mg Injection
ERIS LIFESCIENC...
₹ 1265.00/injection
65% cheaper
Feriosa 1000mg Injection
AUREATE HEALTHC...
₹ 2419.00/injection
34% cheaper
Glenferr FCM 1K Injection
GLENMARK PHARMA...
₹ 2905.00/injection
21% cheaper
Better Service Satisfied Customers
Introduction
Encicarb 1K Injection contains Ferric Carboxymaltose, an iron replacement medicine used to replenish the body's iron stores. Each 20 mL injection contains 1,000 mg of elemental iron, equivalent to 50 mg of iron per mL.
This medicine is administered intravenously, either as a slow injection into a vein or as an infusion. It is prescribed when iron deficiency needs to be corrected and oral iron supplements are ineffective, cannot be tolerated or are unsuitable for the patient's condition.
Uses of Encicarb 1K Injection
Encicarb 1K Injection is used for:
Iron deficiency anaemia: Helps replenish iron levels in people with iron deficiency anaemia when oral iron supplements have not worked adequately or cannot be tolerated.
Iron replacement when rapid correction is needed: Provides iron directly into the bloodstream when a healthcare professional determines that oral supplementation is unsuitable or that iron needs to be replaced more quickly.
Iron deficiency should be confirmed through appropriate blood tests before treatment. The doctor determines the required dose based on the patient's body weight, haemoglobin levels, iron status and medical condition.
How Encicarb 1K Injection Works
Encicarb 1K Injection contains Ferric Carboxymaltose, an iron complex that releases iron for use by the body. Iron is needed to produce haemoglobin, the protein in red blood cells that carries oxygen to different tissues.
When iron levels are low, the body may not produce enough healthy red blood cells, leading to iron deficiency anaemia. By replenishing iron stores, Encicarb 1K Injection supports haemoglobin production and helps the body restore its iron balance.
Interactions of Encicarb 1K Injection with Other Medicines
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take before receiving Encicarb 1K Injection.
Oral iron supplements: Intravenous iron can reduce the absorption of oral iron when both are used together. If oral iron treatment is required, it should generally not be started until at least five days after the last ferric carboxymaltose administration. Follow your doctor's instructions.
Other intravenous iron preparations: Using additional intravenous iron without medical supervision may lead to excessive iron accumulation. Tell your doctor if you have recently received another iron injection or infusion.
Medicines and procedures affecting blood test interpretation: Ferric carboxymaltose may affect the interpretation of certain laboratory results, including some measurements of iron status. Inform your healthcare professional that you have received this injection before undergoing blood tests.
Do not start, stop or change any medicine or supplement without consulting your doctor.
Storage Conditions
Store Encicarb 1K Injection according to the instructions provided on its original packaging.
Do not freeze the injection.
Keep the vial in its original packaging until it is required for use.
Protect the medicine from damage and keep it out of the sight and reach of children.
The injection should be inspected by a healthcare professional before administration. Do not use a damaged vial or one showing visible particles or an unusual appearance.
Product-specific note: The exact storage instructions for Encicarb 1K Injection should be confirmed against its Indian packaging or manufacturer-approved product information before publication.
How to Use Encicarb 1K Injection
Encicarb 1K Injection must be administered intravenously by a qualified healthcare professional. It is not intended for self-administration.
The doctor calculates the required iron dose based on body weight, haemoglobin levels and the extent of iron deficiency.
The injection may be administered directly into a vein as a slow intravenous injection or diluted for intravenous infusion, as appropriate.
The rate of administration and the amount given depend on the prescribed dose and the applicable product instructions.
A 1,000 mg vial does not mean that every patient should receive the entire contents. The prescribed dose must be calculated individually.
Your healthcare professional will monitor you during and after administration for signs of an allergic reaction or other adverse effects. Observation for at least 30 minutes after administration is recommended in the prescribing information for ferric carboxymaltose.
Blood tests may be repeated to assess haemoglobin levels and iron stores and to determine whether further treatment is needed.
Do not receive additional doses unless your doctor has assessed your iron levels and confirmed that further treatment is appropriate.
Safety Advice
Pregnancy
There is limited information about the use of ferric carboxymaltose during pregnancy. Intravenous iron should only be used when clearly necessary after the potential benefits and risks have been assessed. Inform your doctor if you are pregnant or planning to become pregnant.
Breast Feeding
Small amounts of iron may pass into breast milk. Available information suggests that the transfer of iron into breast milk after ferric carboxymaltose administration is low. Discuss your treatment needs with your doctor before receiving this injection while breastfeeding.
Lungs
Inform your doctor if you have asthma, a history of severe allergies or other breathing problems. Ferric carboxymaltose can occasionally cause serious hypersensitivity reactions, including difficulty breathing. Seek immediate medical attention if you develop breathing difficulties, swelling or other signs of a severe allergic reaction during or after administration.
Liver
Tell your doctor if you have liver disease. Intravenous iron requires careful assessment in people with liver dysfunction, particularly when iron accumulation may worsen the condition. Your doctor may need to assess your iron levels and liver health before recommending treatment.
Alcohol
Tell your doctor about your alcohol consumption, particularly if you have liver disease or another condition that may affect your treatment. Your doctor can advise you on whether any precautions are needed based on your health and prescribed treatment.
Driving
Encicarb 1K Injection is not generally expected to impair driving ability. However, some people may experience dizziness or other reactions after administration. Avoid driving or operating machinery if you feel dizzy, faint or unwell.
Side Effects
Encicarb 1K Injection may cause side effects in some people, although not everyone experiences them.
Common side effects
Nausea
Headache
Dizziness
Flushing
High blood pressure
Reactions at the injection or infusion site
Low phosphate levels in the blood
Most reactions are manageable, but inform your healthcare professional if symptoms persist or become troublesome.
Serious side effects
Seek immediate medical attention if you experience symptoms of a serious allergic reaction, including:
Difficulty breathing or wheezing
Swelling of the face, lips, tongue or throat
Severe rash, itching or widespread hives
Sudden dizziness, fainting or collapse
Ferric carboxymaltose can also cause significantly reduced phosphate levels in the blood, sometimes for a prolonged period. Contact your doctor if you develop unusual or persistent tiredness, muscle weakness, muscle pain or bone pain, particularly after repeated treatment.
The medicine can also cause brown skin discolouration if it leaks outside the vein during administration. Inform the healthcare professional immediately if you experience pain, swelling or a burning sensation around the injection site.
Expert Tips
Have your iron deficiency confirmed through appropriate blood tests before starting treatment.
Tell your doctor if you have previously experienced an allergic reaction to intravenous iron preparations.
Inform your doctor about any existing liver disease, asthma, severe allergies or other relevant medical conditions.
Do not take additional iron supplements without discussing them with your doctor.
Attend follow-up appointments so your haemoglobin and iron stores can be assessed.
Ask your doctor whether phosphate monitoring is necessary, particularly if you receive repeated courses of ferric carboxymaltose or have risk factors for low phosphate levels.
Report unusual fatigue, muscle weakness or bone pain that develops after treatment.
Tell your healthcare professional if you experience pain, swelling or skin discolouration around the injection site.
Remain under medical observation for the recommended period after receiving the injection, as serious allergic reactions can occur.
Do not assume that the entire 1,000 mg vial is the correct dose for you. Your doctor must calculate the amount required for your condition.
FAQs
Q1.
What is Encicarb 1K Injection used for?
Encicarb 1K Injection is used to replenish iron stores in people with iron deficiency when oral iron supplements are ineffective, cannot be tolerated or are unsuitable. It may be prescribed when iron replacement needs to be delivered more quickly.
Q2.
What is the composition of Encicarb 1K Injection?
Encicarb 1K Injection contains Ferric Carboxymaltose equivalent to 1,000 mg of elemental iron in 20 mL. Its concentration is 50 mg of iron per mL.
Q3.
How is Encicarb 1K Injection administered?
Encicarb 1K Injection is administered intravenously by a qualified healthcare professional. Depending on the prescribed dose and product instructions, it may be given as a slow injection into a vein or as an infusion.
Q4.
How often should Encicarb 1K Injection be given?
The frequency depends on the patient's iron deficiency, body weight, haemoglobin levels and response to treatment. Some patients may require additional doses, while others may need only one administration. Your doctor determines the appropriate treatment schedule.
Q5.
Can Encicarb 1K Injection be used during pregnancy?
Encicarb 1K Injection should only be used during pregnancy when clearly necessary and after a doctor has assessed the potential benefits and risks. Inform your doctor if you are pregnant or planning to become pregnant.
Q6.
Can people with liver disease receive Encicarb 1K Injection?
People with liver disease should consult their doctor before receiving Encicarb 1K Injection. Intravenous iron may require additional precautions in patients with liver dysfunction, particularly when iron accumulation could worsen the condition.
Q7.
What are the side effects of Encicarb 1K Injection?
Common side effects include nausea, headache, dizziness, flushing, high blood pressure and injection-site reactions. Reduced phosphate levels can also occur. Seek immediate medical attention if you develop breathing difficulties, facial swelling or other signs of a serious allergic reaction.
Q8.
Can Encicarb 1K Injection be given with oral iron supplements?
Oral iron supplements may be less effectively absorbed when used alongside intravenous iron. If oral iron treatment is required, it should generally be delayed for at least five days after the last ferric carboxymaltose administration. Follow your doctor's advice before restarting supplements.
Q9.
What should I do if I miss a scheduled dose of Encicarb 1K Injection?
Contact your doctor or healthcare provider to arrange the next administration. Do not receive an extra dose or change your treatment schedule without medical advice.
Q10.
Does Encicarb 1K Injection need to be refrigerated?
Do not assume that refrigeration is necessary. Follow the storage instructions on the Encicarb 1K Injection packaging or those provided by the manufacturer. The product-specific Indian storage instructions should be verified before publication.
Fact Box
Molecule name | Ferric Carboxymaltose |
Therapeutic class | Iron replacement medicine |
Pharmacological class | Parenteral iron preparation |
Indications | Iron deficiency and iron deficiency anaemia when intravenous iron replacement is clinically indicated |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Prakruthi Madhusudan
MSc Bioinformatics

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 28 Oct 2026 | 12:42 PM (IST)

Want to know more?
Read Our Editorial Policy







